Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2026-02-21 @ 11:17 PM
Study NCT ID:
NCT01354457
Status:
UNKNOWN
Last Update Posted:
2014-06-25
First Post:
2009-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+
Sponsor:
Nantes University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-06
Completion Date Type:
ESTIMATED
First Submit Date:
2009-07-17
First Submit QC Date:
None
Study First Post Date:
2011-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-24
Last Update Post Date:
2014-06-25
Last Update Post Date Type:
ESTIMATED